Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Fleitas · SciRah

Researcher profile · Semantic Scholar

T. Fleitas

Share profile

T. Fleitas — researcher profile on SciRah

h-index: 23
Works: 101
Citations: 3,794

Most-cited papers

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
F. Lordick, F. Carneiro, S. Cascinu, T. Fleitas +4 more
2022Annals of Oncology1,354 citations Open access
Semantic Scholar
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
V. Gambardella, J. Castillo, N. Tarazona, F. Gimeno-Valiente +7 more
2020Cancer Treatment Reviews298 citations Open access
Semantic Scholar
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
S. Derks, X. Liao, A. Chiaravalli, Xinsen Xu +8 more
2016OncoTarget293 citations Open access
Semantic Scholar
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.
N. Tarazona, F. Gimeno-Valiente, V. Gambardella, S. Zuniga +16 more
2019Annals of Oncology260 citations Open access
Semantic Scholar
Personalized Medicine: Recent Progress in Cancer Therapy
V. Gambardella, N. Tarazona, J. Cejalvo, P. Lombardi +5 more
2020Cancers253 citations Open access
Semantic Scholar
Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas
S. Derks, L. D. de Klerk, X. Xu, T. Fleitas +16 more
2020Annals of Oncology154 citations Open access
Semantic Scholar
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
K. Shitara, T. Fleitas, H. Kawakami, G. Curigliano +28 more
2024ESMO Open119 citations Open access
Semantic Scholar
Checkpoint inhibitors for gastroesophageal cancers: Dissecting heterogeneity to better understand their role in first line and adjuvant therapy.
E. Smyth, V. Gambardella, A. Cervantes, T. Fleitas
2021Annals of Oncology117 citations Open access
Semantic Scholar
Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma
G. Reynés, V. Vila, María M. Martín, A. Parada +3 more
2011Journal of Neuro-Oncology105 citations
Semantic Scholar
“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
F. Papaccio, B. García-Micó, F. Gimeno-Valiente, M. Cabeza-Segura +16 more
2023Journal of experimental & clinical cancer research : CR66 citations Open access
Semantic Scholar
Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer
T. Fleitas, V. Martínez-Sales, V. Vila, E. Réganon +5 more
2012PLoS ONE65 citations Open access
Semantic Scholar
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer
V. Gambardella, F. Gimeno-Valiente, N. Tarazona, C. Ciarpaglini +8 more
2018Clinical Cancer Research59 citations
Semantic Scholar
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
F. Papaccio, S. Roselló, M. Huerta, V. Gambardella +4 more
2020Cancers49 citations Open access
Semantic Scholar
Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer
M. Ibarrola-Villava, M. Llorca-Cardenosa, N. Tarazona, C. Mongort +6 more
2015OncoTarget44 citations Open access
Semantic Scholar
Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer
T. S. Groen-van Schooten, Rosalia Franco Fernandez, N. V. van Grieken, Emma N. Bos +8 more
2024Journal for ImmunoTherapy of Cancer43 citations Open access
Semantic Scholar
Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer
J. Martín-Arana, F. Gimeno-Valiente, T. Henriksen, B. García-Micó +24 more
2025Nature Cancer39 citations Open access
Semantic Scholar
VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer
T. Fleitas, V. Martínez-Sales, V. Vila, E. Réganon +5 more
2013Clinical and Translational Oncology38 citations
Semantic Scholar
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer
N. Tarazona, F. Gimeno-Valiente, V. Gambardella, M. Huerta +17 more
2020ESMO Open34 citations Open access
Semantic Scholar
Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
T. Kroese, P. V. van Rossum, M. Nilsson, F. Lordick +20 more
2022European Journal of Surgical Oncology33 citations Open access
Semantic Scholar
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
D. Meulendijks, W. Jacob, E. Voest, M. Mau-Sørensen +27 more
2017Clinical Cancer Research33 citations Open access
Semantic Scholar
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study
V. Gambardella, P. Lombardi, J. Carbonell-Asins, N. Tarazona +26 more
2021British Journal of Cancer30 citations Open access
Semantic Scholar
Circulating Endothelial Cells and Procoagulant Microparticles in Patients with Glioblastoma: Prognostic Value
G. Reynés, V. Vila, T. Fleitas, E. Réganon +3 more
2013PLoS ONE29 citations Open access
Semantic Scholar
Towards precision oncology for anti-HER2 blockade in gastroesophageal adenocarcinoma.
V. Gambardella, T. Fleitas, N. Tarazona, J. Cejalvo +7 more
2019Annals of Oncology24 citations Open access
Semantic Scholar
Smart CAR-T Nanosymbionts: archetypes and proto-models
J. Baena, J. S. Victoria, Alejandro Toro-Pedroza, C. Aragón +13 more
2025Frontiers in Immunology21 citations Open access
Semantic Scholar
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress
V. Gambardella, T. Fleitas, N. Tarazona, F. Papaccio +5 more
2020Journal of Clinical Medicine21 citations Open access
Semantic Scholar
Advances in the management of locally advanced rectal cancer: A shift toward a patient-centred approach to balance outcomes and quality of life.
M. Airoldi, Susana Roselló, N. Tarazona, M. Huerta +6 more
2025Cancer Treatment Reviews19 citations Open access
Semantic Scholar
MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicine.
T. Fleitas, M. Ibarrola-Villava, G. Ribas, A. Cervantes
2016Cancer Treatment Reviews19 citations
Semantic Scholar
Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment
M. Llorca-Cardenosa, T. Fleitas, M. Ibarrola-Villava, M. Peña-Chilet +9 more
2016OncoTarget17 citations Open access
Semantic Scholar
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally
T. V. van Schooten, S. Derks, E. Jiménez-Martí, F. Carneiro +18 more
2022BMC Cancer14 citations Open access
Semantic Scholar
ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients.
M. Huerta, J. Martín-Arana, F. Gimeno-Valiente, J. Carbonell-Asins +18 more
2024Translational Research: The Journal of Laboratory and Clinical Medicine13 citations Open access
Semantic Scholar
Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma
G. Reynés, V. Martínez-Sales, V. Vila, C. Balañà +8 more
2016Anti-Cancer Drugs13 citations
Semantic Scholar
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations
T. S. Groen-van Schooten, M. Harrasser, Jens Seidel, Emma N. Bos +13 more
2024Frontiers in Immunology12 citations Open access
Semantic Scholar
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype
N. T. Llavero, F. Gimeno-Valiente, V. Gambardella, M. Huerta +16 more
2019Annals of Oncology12 citations Open access
Semantic Scholar
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries
P. Medel-Jara, Diego Reyes Placencia, Eduardo Fuentes-López, Ó. Corsi +28 more
2024United European Gastroenterology journal11 citations Open access
Semantic Scholar
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology
M. Ibarrola-Villava, T. Fleitas, M. Llorca-Cardenosa, C. Mongort +9 more
2016OncoTarget11 citations Open access
Semantic Scholar
A first-in-human trial of RG7116, a glycoengineered monoclonal antibody targeting HER3, in patients with advanced/metastatic tumors of epithelial cell origin expressing HER3 protein.
D. Meulendijks, M. Lolkema, E. Voest, M. D. de Jonge +15 more
201311 citations
Semantic Scholar
Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer
T. Fleitas, V. Martínez-Sales, J. Gomez-Codina, María M. Martín +1 more
2010Clinical and Translational Oncology11 citations
Semantic Scholar
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids
F. Papaccio, M. Cabeza-Segura, B. García-Micó, F. Gimeno-Valiente +15 more
2025Journal of experimental & clinical cancer research : CR10 citations Open access
Semantic Scholar
How organoids can improve personalized treatment in patients with gastro-esophageal tumors.
M. Cabeza-Segura, B. García-Micó, M. La Noce, G. F. Nicoletti +6 more
2023Current opinion in pharmacology (Print)9 citations Open access
Semantic Scholar
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
M. Cabeza-Segura, V. Gambardella, F. Gimeno-Valiente, J. Carbonell-Asins +17 more
2022British Journal of Cancer9 citations Open access
Semantic Scholar
Enhancing precision oncology: the role of molecular tumor boards in early identification and targeted treatment of ESCAT II-III alterations
V. Seguí, J. Carbonell-Asins, J. Martín-Arana, M. García-Bartolomé +16 more
2025ESMO Open7 citations
Semantic Scholar
Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project
R. Dienstmann, E. Ruíz-García, M. Alsina, F. Ruíz-Pace +52 more
2025ESMO Open6 citations Open access
Semantic Scholar
Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer.
V. Gambardella, T. Fleitas, A. Cervantes
2019Annals of Oncology6 citations Open access
Semantic Scholar
Paraneoplastic hyperinsulinism and secondary hypoglycaemia in a patient with advanced colon cancer: a rare association.
R. Díaz, J. Aparicio, Andrea Mendizábal, M. Faus +3 more
2008World Journal of Gastroenterology5 citations Open access
Semantic Scholar
444OPHASE IB TRIAL TRIAL OF RG7116, A GLYCOENGINEERED MONOCLONAL ANTIBODY TARGETING HER3, IN COMBINATION WITH CETUXIMAB OR ERLOTINIB IN PATIENTS WITH ADVANCED/METASTATIC TUMORS OF EPITHELIAL CELL ORIGIN EXPRESSING HER3 PROTEIN.
U. Lassen, A. C. Ruipérez, T. Fleitas, D. Meulendijks +15 more
2014Annals of Oncology4 citations Open access
Semantic Scholar
Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study
M. Airoldi, A. Cammarota, J. Carbonell-Asins, C. Peña +29 more
2026ESMO Open2 citations Open access
Semantic Scholar
Targeting claudins in gastric cancer: A novel GLOWing strategy in the SPOTLIGHT.
Mario Balsa, Sergio Alonso, Laura Sánchez, C. Bugés +16 more
2026Cancer Treatment Reviews2 citations
Semantic Scholar
Immune profiling of gastric adenocarcinomas in EU and LATAM countries identifies global differences in immune subgroups and microbiome influence
T. S. Groen-van Schooten, M. Cabeza-Segura, R. Ferreira, C. Martínez-Ciarpaglini +37 more
2025British Journal of Cancer2 citations Open access
Semantic Scholar
488P Patient-derived organoids as a tool for modelling localized colorectal cancer
M. F. Gutierrez Bravo, F. Papaccio, M. Cabeza, C. Martínez-Ciarpaglini +13 more
20202 citations Open access
Semantic Scholar
A phase Ib study of lumretuzumab, a glycoengineered monoclonal antibody targeting HER3, in combination with carboplatin and paclitaxel as 1st-line treatment in patients with squamous non-small cell lung cancer
J. Cejalvo, T. Fleitas, E. Felip, A. N. Mendivil +12 more
20162 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Gambardella×20
Invite
V. Gambardella — researcher profile on SciRah
N. Tarazona×18
Invite
N. Tarazona — researcher profile on SciRah
D. Roda×17
Invite
D. Roda — researcher profile on SciRah
C. Martínez-Ciarpaglini×16
Invite
C. Martínez-Ciarpaglini — researcher profile on SciRah

×16

Invite

M. Huerta — researcher profile on SciRah

A. Cervantes×16

Invite

A. Cervantes — researcher profile on SciRah

J. Castillo×12

Invite

J. Castillo — researcher profile on SciRah

F. Gimeno-Valiente×12

Invite

F. Gimeno-Valiente — researcher profile on SciRah

S. Roselló×12

Invite

S. Roselló — researcher profile on SciRah

J. Carbonell-Asins×10

Invite

J. Carbonell-Asins — researcher profile on SciRah

Invite

F. Papaccio — researcher profile on SciRah

M. Cabeza-Segura×7

Invite

M. Cabeza-Segura — researcher profile on SciRah